Leishman, A.W.D. : Merits of reducing high blood-pressure. Lancet, i:1284, 1963.
2.
Leishman, A.W.D. , Matthews, H.L., and Smith, A.J.: Guanethidine; hypotensive drug with prolonged action. Lancet, ii:1044, 1959.
3.
Leishman, A.W.D. , and Sandler, G.: Hastening the control of blood pressure by guanethidine. Lancet, i:668, 1965.
4.
Karvonen, M. , Orma, E., Keys , A., Fidanza, F., and Brozek, J.: Cigarette smoking, serum cholesterol, blood pressure and body fatness. Lancet, i:492, 1959.
5.
Leishman, A.W.D. : Hypertension-treated and untreated. A study of 400 cases. Brit. M. J., i: 1361, 1959.
6.
Shillito, J. : Merits of reducing high blood pressure. Lancet, ii:297, 1963.
7.
Marshall, J. : A trial of long-term hypotensive therapy in cerebrovascular disease. Lancet i:10, 1964.
8.
North, J.D.K. , Williams, J.C.P., and Howie, R.N.: Severe hypertension treated with ganglion-blocking drugs in a general hospital. Brit. M. J., i: 1426, 1961.
9.
Hood, B., Bjork, S., Samnerstedt, R., and Angarall, G.: Analysis of mortality and survival in actively-treated hypertensive disease . Acta Med. Scandinav., 174: 393, 1963 .
10.
Lowther, C.P. , and Turner, W.D.: Guanethidine in the treatment of hypertension . Brit. M. J., ii: 776, 1963.
11.
Gaffney, T.E. , and Braunwald, E.: Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure . Am. J. Med., 34: 320, 1963.
Wilson, C., and Abrahams, D.G.: The treatment of hypertension in primary renal disease. Brit. M. Bull., 13: 39, 1957.
14.
Luke, R.G., and Kennedy, A.C.: Methyldopa in the treatment of hypertension due to chronic renal disease . Brit. M. J., i: 27, 1964.
15.
Onesti, G., Brest, A.N., Novack, P., and Moyer, J.H.: Pharmacodynamic effects and clinical use of alpha-methyldopa in the treatment of essential hypertension. Am. J. Cardiol., 9: 863, 1962.
